*By Jacqueline Corba*
MedMen, an American cannabis company based in Los Angeles, began trading on the Canadian Stock Exchange on Tuesday, earning a valuation of $1.1 billion.
"Today is day one," co-founder and CEO Adam Bierman said in an interview with Cheddar. "There is nothing quick in regards to anything having to do with our industry. This is a long play."
MedMen has 18 licensed facilities in California, Nevada, and New York. The company recently opened a medical marijuana dispensary on 5th Avenue in Manhattan with a high-tech and minimalist design that has prompted comparisons with an Apple store.
But unlike tech companies, even legal cannabis companies in the United States don't have access to institutional capital. That's why MedMen had to go to Canada.
"They are the second American cannabis company to do it, they are not going to be the last," said Greg Zeman, associate editor at Cannabis Now. "Everybody is looking for capital and affordable capital is not in heavy supply down here, and it is pretty abundant when you get up to Canada. It's like any rushーeveryone is trying to get in it now."
With an infusion of capital from the company's public listing ー six percent of the company was opened up for public sharesー MedMen's Bierman said the company will expand its retail operations and open new growing facilities. And maybe sometime in the future, the company could be listed in New York and Bierman can ring the bell at the New York Stock Exchange.
"Prohibition will end here in the U.S.," Bierman said. "Bureaucracy is there for a reason, I don't think we want to change laws overnight here in this country. I think its good it goes through a process and takes time."
The next cannabis company to go through a similar process may be Orchid Essentials. That company's co-founder, Corey Mangold, told Cheddar's CannaBiz he plans to take his company public on the Canadian stock market in the fall.
Mangold laments the fact that he can't list his company in the United States, but said he was confident that change is coming to medical and recreational use of marijuana.
"It's time that we grab a hold and make a change that is long overdue," Mangold said.
Oracle soars as it cashes in on the AI boom, Plus: Starbucks shares continue to fall under its new CEO, and does anybody actually want a new iPhone Air?
Swedish buy now, pay later company Klarna is making its highly anticipated public debut on the New York Stock Exchange Wednesday, the latest in a run of high-profile initial public offerings this year. The offering priced at $40 Tuesday, above the forecasted range of $35 to $37 a share, valuing the company at more than $15 billion. The valuation easily makes Klarna one of the biggest IPOs so far in 2025, which has been one of the busier years for companies going public. Other popular IPOs so far this year include the design software company Figma and Circle Internet Group, which issues the USDC stablecoin..
Oracle co-founder Larry Ellison wrested the title of the world’s richest man from longtime holder Elon Musk early Wednesday as stock in his software giant rocketed more than a third in a stunning few minutes of trading. That is according to wealth tracker Bloomberg. A college dropout, the 81-year-old Ellison is now worth $393 billion, Bloomberg says, several billion more than Musk, who had been the world’s richest for four years. The switch in the ranking came after a blockbuster earnings report from Oracle. Forbes still has Musk as the richest, however, valuing his private businesses much higher.
Aurimas Sabulis, CEO of Dextall, unveils how AI‑driven prefabricated façades slash design time by 80%, labor by 87%, and accelerate affordable housing delivery.
Online broker Robinhood Markets will join the S&P 500 index Online broker Robinhood Markets will join the S&P 500 index as its stock rides higher on a cryptocurrency wave.
